Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (251-260 of 645) with videos related to

Pageof 65
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2017
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesisPaola Rogliani, Maria Gabriella Matera, Josuel Ora, et al.
Expert Opinion on Emerging Drugs|April 22, 2020
Emerging muscarinic receptor antagonists for the treatment of asthmaMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Trends in Pharmacological Sciences|June 1, 2019
Thiol-Based Drugs in Pulmonary Medicine: Much More than MucolyticsMario Cazzola, Luigino Calzetta, Clive Page, et al.
Expert Opinion on Emerging Drugs|July 24, 2018
Emerging antibacterial and antiviral drugs for treating respiratory tract infectionsMarco Mantero, Paola Rogliani, Mario Cazzola, et al.
Drugs|October 7, 2020
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic AgentMario Cazzola, Clive Page, Paola Rogliani, et al.
British Journal of Clinical Pharmacology|May 6, 2022
Dual bronchodilation for the treatment of COPD: From bench to bedsideMario Cazzola, Clive Page, Paola Rogliani, et al.
Expert Opinion on Pharmacotherapy|May 27, 2022
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthmaMario Cazzola, Paola Rogliani, Silvio Naviglio, et al.
Expert Review of Clinical Pharmacology|February 9, 2021
Sex differences in COPD managementMaria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Current Pharmaceutical Design|March 20, 2014
New treatments for COPD in the elderlyMaria Gabriella Matera, Luigino Calzetta, Paola Rogliani, et al.
Respiratory Medicine|January 14, 2026
Fractional Exhaled Nitric Oxide in Monitoring Biological Treatment for Severe Asthma in Adults: Clinical Implications and Future PerspectivesMauro Maniscalco, Claudio Candia, Pasquale Ambrosino, et al.
Pageof 65

Showing results (251-260 of 645) with videos related to

Sort By:
Pageof 65
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2017
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesisPaola Rogliani, Maria Gabriella Matera, Josuel Ora, et al.
Expert Opinion on Emerging Drugs|April 22, 2020
Emerging muscarinic receptor antagonists for the treatment of asthmaMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Trends in Pharmacological Sciences|June 1, 2019
Thiol-Based Drugs in Pulmonary Medicine: Much More than MucolyticsMario Cazzola, Luigino Calzetta, Clive Page, et al.
Expert Opinion on Emerging Drugs|July 24, 2018
Emerging antibacterial and antiviral drugs for treating respiratory tract infectionsMarco Mantero, Paola Rogliani, Mario Cazzola, et al.
Drugs|October 7, 2020
Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic AgentMario Cazzola, Clive Page, Paola Rogliani, et al.
British Journal of Clinical Pharmacology|May 6, 2022
Dual bronchodilation for the treatment of COPD: From bench to bedsideMario Cazzola, Clive Page, Paola Rogliani, et al.
Expert Opinion on Pharmacotherapy|May 27, 2022
An update on the currently available and emerging synthetic pharmacotherapy for uncontrolled asthmaMario Cazzola, Paola Rogliani, Silvio Naviglio, et al.
Expert Review of Clinical Pharmacology|February 9, 2021
Sex differences in COPD managementMaria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Current Pharmaceutical Design|March 20, 2014
New treatments for COPD in the elderlyMaria Gabriella Matera, Luigino Calzetta, Paola Rogliani, et al.
Respiratory Medicine|January 14, 2026
Fractional Exhaled Nitric Oxide in Monitoring Biological Treatment for Severe Asthma in Adults: Clinical Implications and Future PerspectivesMauro Maniscalco, Claudio Candia, Pasquale Ambrosino, et al.
Pageof 65